GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $207,000 | -1.0% | 4,759 | +0.5% | 0.02% | 0.0% |
| Q4 2021 | $209,000 | -14.3% | 4,736 | -26.9% | 0.02% | -62.1% |
| Q3 2020 | $244,000 | -6.2% | 6,482 | +1.9% | 0.06% | -14.7% |
| Q2 2020 | $260,000 | +7.0% | 6,363 | -1.1% | 0.07% | -18.1% |
| Q1 2020 | $243,000 | -23.1% | 6,434 | -4.4% | 0.08% | 0.0% |
| Q4 2019 | $316,000 | +11.3% | 6,732 | +1.1% | 0.08% | +1.2% |
| Q3 2019 | $284,000 | +14.5% | 6,660 | +7.3% | 0.08% | +2.5% |
| Q2 2019 | $248,000 | +8.8% | 6,205 | +13.3% | 0.08% | +8.1% |
| Q1 2019 | $228,000 | +132.7% | 5,475 | +113.2% | 0.07% | +76.2% |
| Q4 2018 | $98,000 | -6.7% | 2,568 | -4.1% | 0.04% | -12.5% |
| Q1 2018 | $105,000 | +218.2% | 2,677 | +185.1% | 0.05% | +220.0% |
| Q4 2017 | $33,000 | – | 939 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |